Compass Therapeutics to Commence Trading on the OTCQB Venture Market Under the Symbol “CMPX”

BOSTON–(BUSINESS WIRE)–Compass Therapeutics, Inc. (OTCQB: CMPX), a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies, announced today that shares of the companys common stock have been cleared for trading on the OTCQB Venture Market in the United States. The Companys shares will trade under the ticker symbol “CMPX”, effective at the market open on March 5, 2021.

Click here to view the original article.